Agnathia-otocephaly complex in a fetus with maternal use of topical 1% salicylate.
Department of Medical Genetics, University of Calgary, Alberta Children's Hospital, Calgary, Alberta Department of Pathology and Molecular Medicine Department of Obstetrics and Gynecology, McMaster University Medical Centre, McMaster University, Hamilton, Ontario, Canada.
Aneal
A
Khan
Jacqueline
J
Bourgeois
Patrick
P
Mohide
D000014:Abnormalities, Drug-Induced; D004423:Ear / Q000002:abnormalities*; D005260:Female; D006801:Humans; D008297:Male; D008334:Mandible / Q000002:abnormalities*; D018811:Maternal Exposure; D011247:Pregnancy; D020156:Salicylic Acid / Q000009:adverse effects*; D050497:Stillbirth
D020156:Salicylic Acid